Johnson & Johnson Insider Trading
Every director, officer and 10% holder of Johnson & Johnson has to report each trade in its stock within two business days of making it. This is those filings.
JNJ on carbonthat →Purchases and sales
Open-market trades only — the lines where someone chose to buy or sell at the going price.
| Insider | Action | Value |
|---|---|---|
| Timothy SchmidEVP, WW Chair, MedTech2026-09-0211.1K shat $274.74 | Sale | $3M |
| Timothy SchmidEVP, WW Chair, MedTech2026-09-0222.5K shat $274.74 | Sale | $6.2M |
| Jennifer L TaubertEVP, WWC. Innovative Medicine2026-08-1715K shat $263.36 | Sale | $4M |
| Joaquin DuatoCEO and Chairman of the Board2026-08-1321K shat $262.00 | Sale | $5.5M |
| Joaquin DuatoCEO and Chairman of the Board2026-08-13102.3K shat $261.00 | Sale | $26.7M |
| Elizabeth ForminardEVP, Chief Legal Officer2026-08-069.3K shat $257.76 | Sale | $2.4M |
| Elizabeth ForminardEVP, Chief Legal Officer2026-08-066.6K shat $255.93 | Sale | $1.7M |
| Joaquin DuatoCEO and Chairman of the Board2026-08-0542K shat $258.06 | Sale | $10.8M |
| Joaquin DuatoCEO and Chairman of the Board2026-08-056.5K shat $258.74 | Sale | $1.7M |
| Vanessa BroadhurstEVP, Global Corp Affairs2026-07-2023.1K shat $251.27 | Sale | $5.8M |
Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
More on JNJ
Follow Johnson & Johnson (JNJ) by email
New trades in Johnson & Johnson (JNJ) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.